Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of RNA-Targeting Small Molecules: Challenges and Future Directions. | MedComm (2020) | 2025 | 40859960 | PubTator, text mining | PubMed |
| Newborn Screening Program for Spinal Muscular Atrophy in the Campania Region (Italy): Current Limitations and Potential Perspectives. | Int J Neonatal Screen | 2025 | 40843906 | PubTator, text mining | PubMed |
| A multiplex allele specific PCR capillary electrophoresis (mASPCR-CE) assay for simultaneously analysis of SMN1/SMN2/NAIP copy number and SMN1 loss-of-function variants. | Clin Chem Lab Med | 2025 | 40824197 | PubTator, text mining | PubMed |
| Correlation Between the Motor Outcomes and SMN2 and NAIP Gene Copy Numbers Among North Indian Children with Spinal Muscular Atrophy. | Ann Indian Acad Neurol | 2025 | 40820838 | PubTator, text mining | PubMed |
| A cost-utility analysis of newborn screening for spinal muscular atrophy in Canada. | Orphanet J Rare Dis | 2025 | 40804727 | PubTator, text mining | PubMed |
| Risdiplam in Presymptomatic Spinal Muscular Atrophy. | N Engl J Med | 2025 | 40802943 | PubTator, text mining | PubMed |
| Neurodevelopmental screening in children with early-onset spinal muscular atrophy in the treatment era: a strengths-based cohort study. | Brain Commun | 2025 | 40799279 | PubTator, text mining | PubMed |
| Evaluating Therapeutic Outcomes in Spinal Muscular Atrophy: An Indian Experience. | Ann Indian Acad Neurol | 2025 | 40770841 | PubTator, text mining | PubMed |
| Ergothioneine supplementation improves pup phenotype and survival in a murine model of spinal muscular atrophy. | FEBS Lett | 2025 | 40768667 | PubTator, text mining | PubMed |
| Clinical Characteristics, Genotypes, and Treatment Outcomes in 133 Patients With Spinal Muscular Atrophy: A Retrospective Cohort. | Acta Paediatr | 2025 | 40762286 | PubTator, text mining | PubMed |
| Outcomes of genetic testing and prenatal diagnosis of spinal muscular atrophy in Jordan. | J Matern Fetal Neonatal Med | 2025 | 40754463 | PubTator, text mining | PubMed |
| Ketosis-prone Diabetes as a Presentation of New-onset Diabetes in a Patient With Spinal Muscular Atrophy Type III. | JCEM Case Rep | 2025 | 40741597 | PubTator, text mining | PubMed |
| In Vitro Evaluation of Antisense-Mediated Exon Inclusion for Spinal Muscular Atrophy. | Methods Mol Biol | 2025 | 40720033 | PubTator, text mining | PubMed |
| Pre-mRNA Splicing Modulation by Antisense Oligonucleotides. | Methods Mol Biol | 2025 | 40720032 | PubTator, text mining | PubMed |
| Molecular basis of the autoregulatory mechanism of motor neuron-related splicing factor 30. | J Biol Chem | 2025 | 40716741 | PubTator, text mining | PubMed |
| Complex genetic variation in nearly complete human genomes. | Nature | 2025 | 40702183 | PubTator, text mining | PubMed |
| Genotype - phenotype correlation of Spinal Muscular Atrophy in the era of disease modifying therapies: A tertiary Indian experience. | Eur J Paediatr Neurol | 2025 | 40674781 | PubTator, text mining | PubMed |
| Novel Heterocyclic Compounds as SMN2 Modulators for Treating Spinal Muscular Atrophy Via Modulation of SMN2 Splicing. | ACS Med Chem Lett | 2025 | 40666450 | PubTator, text mining | PubMed |
| Epigenetic regulation in spinal muscular atrophy: emerging areas and future directions. | Orphanet J Rare Dis | 2025 | 40640928 | PubTator, text mining | PubMed |
| Prenatal carrier screening for spinal muscular atrophy among pregnant Thai women. | Front Med (Lausanne) | 2025 | 40625353 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=9